Compare CNM & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CNM | RGEN |
|---|---|---|
| Founded | 1996 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Durable Goods | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.0B | 8.2B |
| IPO Year | 2021 | N/A |
| Metric | CNM | RGEN |
|---|---|---|
| Price | $55.96 | $157.57 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 10 |
| Target Price | $60.82 | ★ $170.90 |
| AVG Volume (30 Days) | ★ 3.2M | 724.0K |
| Earning Date | 12-09-2025 | 10-28-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 7.81 | N/A |
| EPS | ★ 2.28 | 0.03 |
| Revenue | ★ $7,764,000,000.00 | $707,890,000.00 |
| Revenue This Year | $4.45 | $17.84 |
| Revenue Next Year | $4.43 | $12.57 |
| P/E Ratio | ★ $24.64 | $5,097.58 |
| Revenue Growth | 8.09 | ★ 11.74 |
| 52 Week Low | $43.18 | $102.97 |
| 52 Week High | $67.18 | $182.52 |
| Indicator | CNM | RGEN |
|---|---|---|
| Relative Strength Index (RSI) | 70.80 | 47.50 |
| Support Level | $44.59 | $160.11 |
| Resistance Level | $50.10 | $165.02 |
| Average True Range (ATR) | 1.68 | 4.97 |
| MACD | 1.17 | -1.27 |
| Stochastic Oscillator | 90.74 | 7.12 |
Core & Main is a leading specialty distributor with a focus on water, wastewater, storm drainage, and fire protection products. The company provides solutions to municipalities, private water companies, and professional contractors across municipal, nonresidential, and residential end markets. The company's specialty products and services are used in the maintenance, repair, replacement, and construction of water and fire protection infrastructure.
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.